Showing 1–6 of 6 results
-
Research | | Open
-
Research |
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
- Dominic G. Rothwell
- , Mahmood Ayub
- , Natalie Cook
- , Fiona Thistlethwaite
- , Louise Carter
- , Emma Dean
- , Nigel Smith
- , Shaun Villa
- , Joanne Dransfield
- , Alexandra Clipson
- , Daniel White
- , Kamrun Nessa
- , Saba Ferdous
- , Matthew Howell
- , Avinash Gupta
- , Bedirhan Kilerci
- , Sumitra Mohan
- , Kris Frese
- , Sakshi Gulati
- , Crispin Miller
- , Allan Jordan
- , Helen Eaton
- , Nicholas Hickson
- , Ciara O’Brien
- , Donna Graham
- , Claire Kelly
- , Sreeja Aruketty
- , Robert Metcalf
- , Jaseela Chiramel
- , Nadina Tinsley
- , Alexander J. Vickers
- , Roopa Kurup
- , Hannah Frost
- , Julie Stevenson
- , Siobhan Southam
- , Dónal Landers
- , Andrew Wallace
- , Richard Marais
- , Andrew M. Hughes
- , Ged Brady
- , Caroline Dive
- & Matthew G. Krebs
-
| Open
-
| Open
-
Reviews | | Open
-
| Open
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
- Natalie Cook
- , Bristi Basu
- , Donna-Michelle Smith
- , Aarthi Gopinathan
- , Jeffry Evans
- , William P Steward
- , Daniel Palmer
- , David Propper
- , Balaji Venugopal
- , Mirela Hategan
- , D Alan Anthoney
- , Lisa V Hampson
- , Michael Nebozhyn
- , David Tuveson
- , Hayley Farmer-Hall
- , Helen Turner
- , Robert McLeod
- , Sarah Halford
- & Duncan Jodrell
